SCOPUS 정보 검색 플랫폼

Volumn 15, Issue 18, 2009, Pages 2293-2295

Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone

(5) Zold, Eva a Nagy, Arpad a Devenyi, Katalin b Zeher, Margit a Barta, Zsolt a

a UNIVERSITY OF DEBRECEN (Hungary)

b Euromedic Diagnostics Szeged Ltd (Hungary)

Author keywords

Adalimumab; Crohn's disease; Pyoderma gangrenosum

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL MASS; ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ABSENCE OF SIDE EFFECTS; ADULT; ARTHRALGIA; ARTICLE; BLOODY DIARRHEA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DRUG MEGADOSE; DRUG RESPONSE; ENTEROCUTANEOUS FISTULA; ERYTHEMA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; PYODERMA GANGRENOSUM; REMISSION; SKIN INFLAMMATION; SKIN ULCER; SPLENOMEGALY; WEAKNESS; PATHOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; HUMANS; PYODERMA GANGRENOSUM;

EID: 67650116192 PISSN: 10079327 EISSN: None Source Type: Journal
DOI: 10.3748/wjg.15.2293 Document Type: Article

Times cited : (46)

References (10)

1
- 0036207249
- The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
- Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880
- (2002) Gastroenterology , vol.122 , pp. 875-880
- Schwartz, D.A.¹ Loftus Jr, E.V.² Tremaine, W.J.³ Panaccione, R.⁴ Harmsen, W.S.⁵ Zinsmeister, A.R.⁶ Sandborn, W.J.⁷

2
- 36649003354
- Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease
- Barrie A, Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 1424-1429
- (2007) Inflamm Bowel Dis , vol.13 , pp. 1424-1429
- Barrie, A.¹ Regueiro, M.²

3
- 26944464643
- Extraintestinal manifestations of inflammatory bowel disease
- Urlep D, Mamula P, Baldassano R. Extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol Dietol 2005; 51: 147-163
- (2005) Minerva Gastroenterol Dietol , vol.51 , pp. 147-163
- Urlep, D.¹ Mamula, P.² Baldassano, R.³

4
- 20544461722
- Extraintestinal manifestations of Crohn's disease
- Juillerat P, Mottet C, Froehlich F, Felley C, Vader JP, Burnand B, Gonvers JJ, Michetti P. Extraintestinal manifestations of Crohn's disease. Digestion 2005; 71: 31-36
- (2005) Digestion , vol.71 , pp. 31-36
- Juillerat, P.¹ Mottet, C.² Froehlich, F.³ Felley, C.⁴ Vader, J.P.⁵ Burnand, B.⁶ Gonvers, J.J.⁷ Michetti, P.⁸

5
- 59249105181
- Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis
- Ermis F, Ozdil S, Akyuz F, Pinarbasi B, Mungan Z. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis. Inflamm Bowel Dis 2008; 14: 1611-1613
- (2008) Inflamm Bowel Dis , vol.14 , pp. 1611-1613
- Ermis, F.¹ Ozdil, S.² Akyuz, F.³ Pinarbasi, B.⁴ Mungan, Z.⁵

6
- 36148978629
- Adalimumab for treatment of pyoderma gangrenosum
- Pomerantz RG, Husni ME, Mody E, Qureshi AA. Adalimumab for treatment of pyoderma gangrenosum. Br J Dermatol 2007; 157: 1274-1275
- (2007) Br J Dermatol , vol.157 , pp. 1274-1275
- Pomerantz, R.G.¹ Husni, M.E.² Mody, E.³ Qureshi, A.A.⁴

7
- 33947517050
- Adalimumab treatment for pyoderma gangrenosum
- Heffernan MP, Anadkat MJ, Smith DI. Adalimumab treatment for pyoderma gangrenosum. Arch Dermatol 2007; 143: 306-308
- (2007) Arch Dermatol , vol.143 , pp. 306-308
- Heffernan, M.P.¹ Anadkat, M.J.² Smith, D.I.³

8
- 18944365123
- Systemic pyoderma gangrenosum responding to infliximab and adalimumab
- Hubbard VG, Friedmann AC, Goldsmith P. Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 2005; 152: 1059-1061
- (2005) Br J Dermatol , vol.152 , pp. 1059-1061
- Hubbard, V.G.¹ Friedmann, A.C.² Goldsmith, P.³

9
- 0036743331
- Pyoderma gangrenosum associated with crohn disease: Effect of TNF-alpha blockade with infliximab
- Ljung T, Staun M, Grove O, Fausa O, Vatn MH, Hellstrom PM. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab. Scand J Gastroenterol 2002; 37: 1108-1110
- (2002) Scand J Gastroenterol , vol.37 , pp. 1108-1110
- Ljung, T.¹ Staun, M.² Grove, O.³ Fausa, O.⁴ Vatn, M.H.⁵ Hellstrom, P.M.⁶

10
- 40749122061
- The effect of medical treatment on patients with fistulizing Crohn's disease: A retrospective study
- Uza N, Nakase H, Ueno S, Inoue S, Mikami S, Tamaki H, Matsuura M, Chiba T. The effect of medical treatment on patients with fistulizing Crohn's disease: a retrospective study. Intern Med 2008; 47: 193-199
- (2008) Intern Med , vol.47 , pp. 193-199
- Uza, N.¹ Nakase, H.² Ueno, S.³ Inoue, S.⁴ Mikami, S.⁵ Tamaki, H.⁶ Matsuura, M.⁷ Chiba, T.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.